Mycobacterial Dihydrofolate Reductase Inhibitors Identified Using Chemogenomic Methods and In Vitro Validation-Reference-Cited by-同舟云学术

Mycobacterial Dihydrofolate Reductase Inhibitors Identified Using Chemogenomic Methods and In Vitro Validation

Published:2015-03-23 Issue:3 Volume:10 Page:e0121492
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Mugumbate Grace,Abrahams Katherine A.,Cox Jonathan A. G.,Papadatos George,van Westen Gerard,Lelièvre Joël,Calus Szymon T.,Loman Nicholas J.,Ballell Lluis,Barros David,Overington John P.,Besra Gurdyal S.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference40 articles.

1. WHO. Global Tuberculosis Control. 2011.

2. Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007–2010;M Zignol;Bull World Health Organ,2012

3. Approaches to target identification and validation for tuberculosis drug discovery: A University of Cape Town perspective;DF Warner;South African Medical Journal,2012

4. WHO. Global Tuberculosis Report. 2013.

5. Integration of virtual and high-throughput screening;J Bajorath;Nat Rev Drug Discov,2002

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploration and Biological Evaluation of 1,3-Diamino-7H-pyrrol[3,2-f]quinazoline Derivatives as Dihydrofolate Reductase Inhibitors;Journal of Medicinal Chemistry;2023-09-12

2. Folate Pathway Inhibitors, An Underestimated and Underexplored Molecular Target for New Anti-tuberculosis Agents;Mini-Reviews in Medicinal Chemistry;2023-09

3. Mycobacterium tuberculosis Dihydrofolate Reductase Inhibitors: State of Art Past 20 Years;BIOINTERFACE RES APP;2023

4. From drugs to targets: Reverse engineering the virtual screening process on a proteomic scale;Frontiers in Drug Discovery;2022-10-20

5. Integrated genomics and chemical biology herald an era of sophisticated antibacterial discovery, from defining essential genes to target elucidation;Cell Chemical Biology;2022-05